Opaleye Management Inc. Cara Therapeutics, Inc. Transaction History

Opaleye Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$16.11 - $25.98 $7.09 Million - $11.4 Million	-440,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$18.28 - $26.91 $8.04 Million - $11.8 Million	440,000 New	440,000 $8.04 Million
Q2 2019 Aug 14, 2019	SELL	$17.68 - $21.57 $3.54 Million - $4.31 Million	-200,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$14.41 - $19.64 $2.88 Million - $3.93 Million	200,000 New	200,000 $3.92 Million
Q4 2018 Feb 14, 2019	SELL	$12.45 - $23.47 $1.62 Million - $3.05 Million	-130,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$17.57 - $23.95 $2.28 Million - $3.11 Million	130,000 New	130,000 $3.11 Million

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $15M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.